What GLP-1 drugs are doing to population health, and who is actually taking them

Weight loss drives bone loss through endocrine, nutritional and mechanical mechanisms

Weight loss raises bone turnover and lowers bone mineral density via endocrine, nutritional, mechanical and microbiota-mediated pathways, with greater loss in older and lean adults and after severe caloric restriction such as with GLP-1 drugs or bariatric surgery.